Published in J Acquir Immune Defic Syndr on October 01, 2013
The Spear and Shield intervention to increase the availability and acceptability of voluntary medical male circumcision in Zambia: a cluster randomised controlled trial. Lancet HIV (2015) 1.49
Proper surgical training and grading of complications for Shang Ring circumcision are necessary. J Acquir Immune Defic Syndr (2013) 0.85
How do you circumcise a nation? The Rwandan case study. BMC Med (2014) 0.83
Lower HIV Risk Among Circumcised Men Who Have Sex With Men in China: Interaction With Anal Sex Role in a Cross-Sectional Study. J Acquir Immune Defic Syndr (2016) 0.81
Authors' reply: Proper surgical training and grading of complications for Shang Ring circumcision are necessary. J Acquir Immune Defic Syndr (2013) 0.75
The characteristics of circular disposable devices and in situ devices for optimizing male circumcision: a network meta-analysis. Sci Rep (2016) 0.75
Circumcision and its effects in Africa. Transl Androl Urol (2017) 0.75
Randomized, controlled intervention trial of male circumcision for reduction of HIV infection risk: the ANRS 1265 Trial. PLoS Med (2005) 42.71
Male circumcision for HIV prevention in young men in Kisumu, Kenya: a randomised controlled trial. Lancet (2007) 38.98
Male circumcision for HIV prevention in men in Rakai, Uganda: a randomised trial. Lancet (2007) 37.69
Voluntary medical male circumcision: modeling the impact and cost of expanding male circumcision for HIV prevention in eastern and southern Africa. PLoS Med (2011) 7.56
Male circumcision for prevention of heterosexual acquisition of HIV in men. Cochrane Database Syst Rev (2009) 4.86
A model for the roll-out of comprehensive adult male circumcision services in African low-income settings of high HIV incidence: the ANRS 12126 Bophelo Pele Project. PLoS Med (2010) 2.43
HIV prevention: male circumcision comparison between a nonsurgical device to a surgical technique in resource-limited settings: a prospective, randomized, nonmasked trial. J Acquir Immune Defic Syndr (2012) 2.34
The number of procedures required to achieve optimal competency with male circumcision: findings from a randomized trial in Rakai, Uganda. BJU Int (2009) 1.84
The Shang Ring device for adult male circumcision: a proof of concept study in Kenya. J Acquir Immune Defic Syndr (2011) 1.80
Adult male circumcision as an intervention against HIV: an operational study of uptake in a South African community (ANRS 12126). BMC Infect Dis (2011) 1.44
Determinants of circumcision and willingness to be circumcised by Rwandan men, 2010. BMC Public Health (2012) 1.32
[A recommendable standard protocol of adult male circumcision with the Chinese Shang Ring: outcomes of 328 cases in China]. Zhonghua Nan Ke Xue (2009) 1.06
[Shang Ring circumcision versus conventional surgical procedures: comparison of clinical effectiveness]. Zhonghua Nan Ke Xue (2010) 1.00
Adult template circumcision: a prospective, randomized, patient-blinded, comparative study evaluating the safety and efficacy of a novel circumcision device. Urology (2010) 0.85
Association between human immunodeficiency virus infection and stiffness of the common carotid artery. Stroke (2010) 1.44
Higher baseline CD4 cell count predicts treatment interruptions and persistent viremia in patients initiating ARVs in rural Uganda. J Acquir Immune Defic Syndr (2013) 1.39
Impact of geographic and transportation-related barriers on HIV outcomes in sub-Saharan Africa: a systematic review. AIDS Behav (2014) 1.31
Point-of-care diagnosis and prognostication of cryptococcal meningitis with the cryptococcal antigen lateral flow assay on cerebrospinal fluid. Clin Infect Dis (2013) 1.19
Improved diagnosis of pleural tuberculosis using the microscopic- observation drug-susceptibility technique. Clin Infect Dis (2008) 1.11
Poor validity of urine dipstick as a screening tool for proteinuria in HIV-positive patients. J Acquir Immune Defic Syndr (2008) 1.00
Duration of Antiretroviral Therapy Adherence Interruption Is Associated With Risk of Virologic Rebound as Determined by Real-Time Adherence Monitoring in Rural Uganda. J Acquir Immune Defic Syndr (2015) 1.00
Persistent HIV-related stigma in rural Uganda during a period of increasing HIV incidence despite treatment expansion. AIDS (2015) 0.95
HIV-Infected Ugandan Women on Antiretroviral Therapy Maintain HIV-1 RNA Suppression Across Periconception, Pregnancy, and Postpartum Periods. J Acquir Immune Defic Syndr (2016) 0.94
Disinhibition in risky sexual behavior in men, but not women, during four years of antiretroviral therapy in rural, southwestern Uganda. PLoS One (2013) 0.90
CD4+ cell count at antiretroviral therapy initiation and economic restoration in rural Uganda. AIDS (2014) 0.89
Malaria is an uncommon cause of adult sepsis in south-western Uganda. Malar J (2013) 0.84
Effects of ascent to high altitude on human antimycobacterial immunity. PLoS One (2013) 0.77
Detection of quinolone-resistant Neisseria gonorrhoeae in urogenital specimens with the use of real-time polymerase chain reaction. Int J STD AIDS (2008) 0.76
Authors' reply: Proper surgical training and grading of complications for Shang Ring circumcision are necessary. J Acquir Immune Defic Syndr (2013) 0.75
Facilitating lymphogranuloma venereum surveillance with the use of real time polymerase chain reaction. Int J STD AIDS (2007) 0.75
D-Dimer Levels and Traditional Risk Factors Are Associated With Incident Hypertension Among HIV-Infected Individuals Initiating Antiretroviral Therapy in Uganda. J Acquir Immune Defic Syndr (2016) 0.75
Prevalence and clinical impacts of HIV-1 intersubtype recombinants in uganda revealed by a near-full-genome population and deep sequencing approaches. AIDS (2017) 0.75
Should abacavir be a first-line alternative for adults with HIV in sub-Saharan Africa? J Acquir Immune Defic Syndr (2017) 0.75
Appraising Viral Load Thresholds and Adherence Support Recommendations in the World Health Organization Guidelines for Detection and Management of Virologic Failure. J Acquir Immune Defic Syndr (2017) 0.75